Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

β-1,4-Gal-T4 Activators

β-1,4-Gal-T4 Activators encompass a spectrum of chemical compounds that increase the enzyme's glycosylation activity through various direct and indirect mechanisms. UDP-Galactose directly serves as the substrate for β-1,4-Gal-T4, enabling it to catalyze the addition of galactose to oligosaccharides, a fundamental step in glycoconjugate biosynthesis. The presence of manganese(II) chloride enhances the enzyme's activity by acting as an essential cofactor, ensuring optimal enzyme conformation and function. N-Acetylglucosamine provides an acceptor molecule for β-1,4-Gal-T4, allowing it to add galactose to form lactosamine structures, thus increasing the enzyme's action in producing complex sugars. In concert with these substrates, Epigallocatechin gallate indirectly upholds the enzyme's activity by inhibiting glycosidases, which degrade glycoconjugates, thereby maintaining the products of β-1,4-Gal-T4's activity.

The activity of β-1,4-Gal-T4 is further modulated by compounds that influence the cellular environment in which the enzyme operates. Forskolin raises intracellular cAMP levels, indirectly promoting glycosylation activity by activating protein kinase A (PKA) that may phosphorylate glycosylation machinery or substrates, thereby enhancing β-1,4-Gal-T4's role. ATP, although not a direct activator, provides the energy for the glycosylation reactions facilitated by β-1,4-Gal-T4, potentially increasing its overall activity. These activators either supply essential substrates and cofactors or modulate the cellular milieu to favor the enzymatic action of β-1,4-Gal-T4, thus increasing its contribution to glycoprotein and glycolipid biosynthesis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

UDP-α-D-Galactose disodium salt

137868-52-1sc-286849
sc-286849A
10 mg
50 mg
$104.00
$198.00
1
(0)

UDP-Galactose is a galactose donor utilized by β-1,4-Gal-T4 in the glycosylation process. The availability of this sugar nucleotide directly enhances the enzymatic activity of β-1,4-Gal-T4 by providing the necessary substrate for the synthesis of glycoproteins and glycolipids.

Manganese(II) chloride beads

7773-01-5sc-252989
sc-252989A
100 g
500 g
$19.00
$31.00
(0)

Manganese(II) chloride is a cofactor for β-1,4-Gal-T4, facilitating the proper folding and catalytic activity of the enzyme. The presence of Mn²⁺ ions enhances the functional activity of β-1,4-Gal-T4 by stabilizing the transition state and contributing to the binding of UDP-galactose.

N-Acetyl-D-glucosamine

7512-17-6sc-286377
sc-286377B
sc-286377A
50 g
100 g
250 g
$94.00
$162.00
$306.00
1
(0)

GlcNAc acts as an acceptor substrate for β-1,4-Gal-T4 in the biosynthesis of lactosamine. The enzyme catalyzes the transfer of galactose to GlcNAc-containing oligosaccharides, thus its availability upscales the activity of β-1,4-Gal-T4 in glycosylation pathways.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Epigallocatechin gallate (EGCG) is known to inhibit glycosidases which could otherwise degrade glycoconjugates. By preventing the breakdown of glycoproteins, EGCG indirectly maintains the functional output of β-1,4-Gal-T4 by preserving its glycosylation products.

Adenosine 5′-Triphosphate, disodium salt

987-65-5sc-202040
sc-202040A
1 g
5 g
$39.00
$75.00
9
(1)

ATP provides the necessary energy for the glycosylation process. While ATP itself is not a direct activator, its availability ensures the energetic support for enzymatic functions including those of β-1,4-Gal-T4, potentially enhancing its activity indirectly.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin elevates intracellular cAMP levels, which can indirectly promote the glycosylation process by activating PKA. PKA phosphorylation can enhance the activity of β-1,4-Gal-T4 indirectly by modifying the glycosylation machinery or its substrates.